Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

Viatris Inc. (VTRS) Cash Flow Statement

Viatris Inc. (VTRS) generated $2.3B of operating cash flow over the twelve months to 2026-06-30, spent $376.0M on capital expenditure and had free cash flow of $2.0B, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

VTRSViatris Inc.Follow VTRS — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
20.7B
P/E TTM
—
Dividend yield
2.7%
52-week
—
Next earnings
5 Nov, in 11 days
LineFY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow1.233.023.002.902.302.322.33
Capital expenditure0.240.460.410.380.330.38-0.38
Free cash flow0.992.562.592.521.981.941.95
Dividends paid——0.590.590.590.58—
Share repurchases0.000.000.000.250.250.50—
Stock-based compensation0.080.110.120.180.150.18—

USD billions · SEC XBRL

Viatris Inc. — questions

What is Viatris Inc.'s operating cash flow?
$2.3B over the twelve months to 2026-06-30.
How much does Viatris Inc. spend on capital expenditure?
$376.0M over the twelve months to 2026-06-30.
What is Viatris Inc.'s free cash flow?
$2.0B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from Viatris Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.